Fresenius Medical Care Launches Analytics Platform for Kidney Replacement Therapy

Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has introduced TherapyWise Analytics, a data analytics platform designed to help healthcare providers monitor and optimize kidney replacement therapy through enhanced clinical insights. TherapyWise is designed to provide retrospective, program-level insight into kidney replacement therapy (KRT) delivered in acute and hospital critical care settings.

The platform analyzes treatment data to provide clinicians with information on therapy performance, patient trends, and operational metrics that can support treatment decisions. TherapyWise Analytics is designed to help care teams identify opportunities to improve dialysis delivery, monitor outcomes, and make more informed decisions using data collected during kidney replacement therapy.

TherapyWise works by securely transmitting data from the NxStage System One with NxView to a cloud‑based platform, where information is aggregated and displayed across predefined performance indicators. TherapyWise is part of Fresenius Medical Care's NxView 4.0 software platform and broader critical care portfolio, which combines digital infrastructure, clinical expertise, and secure data management to support hospital teams responsible for kidney replacement therapy programs.

Fresenius Medical Care said the platform is intended for hospitals and healthcare organizations seeking to improve clinical efficiency while supporting individualized patient care. The analytics capabilities also provide operational visibility that can help providers evaluate treatment performance across patient populations.

Posted by MedCloudInsider Editors on 07/21/2026